|
SUN-627 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: N-004850, NEU-627
Pipeline
Phase 2: 1
Top Sponsors
- Sundance Biosciences, Inc.1
Indications
- Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity1
- Non-Active SPMS1
- Secondary Progressive MS1
- Secondary Progressive MS (SPMS)1
- Primary Progressive MS1
Tampa, Florida1 trial
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Local Institution - Site 103
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.